Updated COVID boosters with omicron targeting expected mid-September pending FDA and CDC approval

New COVID-19 vaccines tweaked to target omicron variants will likely be available to the public in mid-September pending FDA authorization and CDC recommendation.
The vaccines are designed to provide better protection against current and emerging omicron strains like XBB.1.5, Eris, and EG.5.
Only 17% of Americans have received their first booster shot, and officials strongly recommend staying up to date, especially for high-risk groups.
While COVID cases and hospitalizations are lower than previous surges, the virus continues to evolve and immunity wanes over time, underscoring the need for boosters.
Experts advise talking to your healthcare provider about the best timing to get COVID boosters along with flu shots and the new RSV vaccines this fall.